Form 8-K - Current report:
SEC Accession No. 0001144204-16-116174
Filing Date
2016-08-03
Accepted
2016-08-03 14:53:18
Documents
2
Period of Report
2016-08-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v445859_8k.htm 8-K 27562
2 EXHIBIT 10.32 v445859_ex10-32.htm EX-10.32 139194
  Complete submission text file 0001144204-16-116174.txt   168095
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 161803490
SIC: 2836 Biological Products, (No Diagnostic Substances)